Project Grant R01HL175982
- Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $249,000 Project Grant to The Regents of the University of Colorado—Denver on February 16, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the biogenesis and assembly mechanisms of human Ether-A-Go-Go-Related Gene (hERG) 1A/1B ion channels in cardiomyocytes. The research addresses a critical gap in understanding how these potassium channel subunits—encoded by alternate transcripts of the...
- Federal Project Grant Summary The National Heart, Lung and Blood Institute (NHLBI) awarded $151,040 to the University of Wisconsin - Madison on February 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support research on the assembly and localization of hERG channel cotranslational complexes. The project, with completion targeted for August 31, 2026, investigates how ion channels critical to heart electrical signaling are co-regulated during protein biosynthesis. The...
- Federal Project Grant Award Summary Boston Children's Hospital received a $674,620 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025 through August 31, 2027. The award supports investigator-initiated research to elucidate the genetic and developmental basis for coordinated limb growth and proportion regulation. The research employs integrated...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $865,286 to Boston Children's Hospital (The Children's Hospital Corporation) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with a completion date of June 30, 2029. This research initiative will produce a high-resolution spatiotemporal lineage map of cardiac development by integrating advanced lineage tracing, spatial, and single-cell...
- This $161,500 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant is intended to establish basic science-clinical collaborations to understand the molecular mechanisms of heterotaxy, a severe form of congenital heart disease that affects 3-4% of patients with congenital heart defects. The funding will support research at the University of Virginia to...
- Federal Project Grant Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $462,538 Project Grant (CFDA 93.865: Child Health and Human Development Extramural Research) to Magee-Womens Research Institute and Foundation for the period June 1, 2026 through May 31, 2028. This award funds research investigating CHD7-dependent regulation of migration and morphogenesis in the context of CHARGE syndrome, a congenital neurocristopathy caused by...
- This $1,000,000 National Science Foundation project grant supports research at the University of Wisconsin-Madison to develop single cell-level programming of human induced pluripotent stem cell differentiation into chamber-specific cardiomyocytes. The goal is to generate cardiomyocytes from each chamber of the heart through precise control of Wnt and retinoic acid signaling at the single cell level via engineered genetic programs and superstructures. If successful, this approach could establish...
- The federal Project Grant award R03HD113887, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the role of the ZFHX4 gene in lung mesenchyme development and its potential implications for understanding the pathogenesis of lung hypoplasia in congenital diaphragmatic hernia (CDH). The $164,990 award, with a performance period from August 1, 2024 to...
- Project Grant Award Summary Weill Medical College of Cornell University received a $149,190 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded July 28, 2025, with completion targeted for June 27, 2028. The grant funds research to identify the metabolic requirements for the tricarboxylic acid (TCA) cycle in embryonic development, specifically examining the role of...
- Federal Project Grant Summary Boston Children's Hospital received a $809,162 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 15, 2025, with a completion date of June 30, 2030. The research investigates pulmonary ionocyte function and development using induced pluripotent stem cell (iPSC)-derived airway epithelium to advance understanding of cellular mechanisms relevant to cystic...
THE ELECTROPHYSIOLOGICAL PROPERTIES OF EMBRYOS - PROJECT SUMMARY CONGENITAL HEART DISEASE (CHD) LEADS TO SEVERE MORBIDITY AND MORTALITY IN CHILDREN IN THE US AND WORLDWIDE. DESPITE THIS IMPACT ON CHILD HEALTH, WE SIMPLY DO NOT UNDERSTAND THE GENETIC CAUSES OF CHD. INDEED, WE RECENTLY SHOWED THAT ION CHANNELS PLAY A CRITICAL ROLE IN CHD, LR PATTERNING, AND EARLY GERM LAYER SPECIFICATION. WE PREVIOUSLY OUTLINED AN ION CHANNEL SIGNALING NETWORK WHERE ERG CHANNELS SUPPRESS VOLTAGE-GATED CALCIUM CHANNELS AND MTOR SIGNALING ENABLING THE EXIT FROM PLURIPOTENCY TO GERM LAYER DIFFERENTIATION. HOWEVER, THIS STUDY RAISED SEVERAL ADDITIONAL QUESTIONS. FOR EXAMPLE, DO THE GERM LAYERS HAVE DIFFERENT ELECTROPHYSIOLOGICAL PROPERTIES? WHAT ARE THE CALCIUM-RESPONSIVE TRANSCRIPTION FACTORS THAT ACTIVATE MTOR SIGNALING? THE GOAL OF THIS PROPOSAL IS TO ANSWER THESE QUESTIONS. WE PROPOSE, AND OUR PRELIMINARY DATA SUPPORT, THAT ION CHANNELS DEFINE A NEW PARADIGM FOR CELL SIGNALING IN EARLY EMBRYONIC CELLS. OUR DATA SUPPORT AN ELECTROPHYSIOLOGICAL MODEL WHERE SPECIFIC GERM LAYER FATES ARE DEPENDENT ON AN ION CHANNEL NETWORK. OUR OVERARCHING HYPOTHESIS IS THAT ION CHANNELS DEFINE ELECTRICAL MEMBRANE POTENTIAL AND REGULATE VOLTAGE-GATED CA2+ CHANNELS THAT ESTABLISH AN EXIT FROM PLURIPOTENCY TOWARDS SPECIFIC CELL FATES, GASTRULATION, AND LR PATTERNING PROVIDING A PLAUSIBLE MECHANISM FOR OUR PATIENTS WITH HTX AND CHD. OUR ELECTROPHYSIOLOGICAL PATHWAY THEN INTEGRATES WITH BIOCHEMICAL SIGNALING PATHWAYS THAT DEFINE SPECIFIC CELL FATES IN THE EMBRYO. IN THIS PROPOSAL, WE WILL FOCUS ON UNDERSTANDING THE DIFFERENCES IN ELECTRICAL PROPERTIES OF THE DIFFERENT GERM LAYERS USING BOTH ELECTROPHYSIOLOGICAL MEASUREMENTS AND GENE KNOCKDOWN IN XENOPUS. WE WILL THEN ALSO IDENTIFY THE TRANSCRIPTION FACTORS THAT REGULATE MTOR SIGNALING IN THE EARLY EMBRYO. OUR PUBLISHED RESULTS STRONGLY POINT TOWARDS ETS AND CRE TRANSCRIPTION FACTORS, AND WE WILL IDENTIFY PRECISELY WHICH TRANSCRIPTION FACTORS PLAY A KEY ROLE IN MTOR SIGNALING AND PLURIPOTENCY. A MAJOR STRENGTH OF OUR PROPOSAL IS OUR EXPERTISE; WE HAVE FORGED A COLLABORATION BETWEEN XENOPUS DEVELOPMENTAL BIOLOGISTS AND ELECTROPHYSIOLOGISTS THAT WILL ALLOW US TO RIGOROUSLY INVESTIGATE MEMBRANE POTENTIAL AS AN EMBRYONIC PATTERNING MECHANISM.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $584.7k | 5/11/26 | ||
| Not listed | $0 | 3/23/26 | ||
| Not listed | $0 | 3/23/26 | ||
| Not listed | $0 | 2/6/26 | ||
| Not listed | $0 | 2/6/26 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
CSPO821103S | Yale Univ | Project Grant R01HL175982 | $380.5k | 4/30/26 |